These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1692221)

  • 1. FK-506 enters the clinic.
    Thomson AW
    Immunol Today; 1990 Feb; 11(2):35-6. PubMed ID: 1692221
    [No Abstract]   [Full Text] [Related]  

  • 2. FK 506 and orthotopic liver transplantation in the rat.
    Isai H; Painter DM; Sheil AG
    Transplant Proc; 1990 Oct; 22(5):2125-6. PubMed ID: 1699329
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of FK 506 on renal function after liver transplantation.
    McCauley J; Fung J; Jain A; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):17-20. PubMed ID: 1689887
    [No Abstract]   [Full Text] [Related]  

  • 4. FK 506-induced nephrotoxicity in rats.
    Kumano K; Wang G; Endo T; Kuwao S
    Transplant Proc; 1991 Feb; 23(1 Pt 1):512-5. PubMed ID: 1703696
    [No Abstract]   [Full Text] [Related]  

  • 5. FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat.
    Yasunami Y; Ryu S; Kamei T
    Transplantation; 1990 Apr; 49(4):682-6. PubMed ID: 1691535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early trials with FK 506 as primary treatment in liver transplantation.
    Todo S; Fung JJ; Demetris AJ; Jain A; Venkataramanan R; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):13-6. PubMed ID: 1689886
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.
    Zeevi A; Eiras G; Burckart G; Jain A; Kragack A; Venkataramanan R; Todo S; Fung J; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1990 Feb; 22(1):60-3. PubMed ID: 1689902
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB
    Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.
    Monden M; Gotoh M; Kanai T; Valdivia LA; Umeshita K; Endoh W; Nakano Y; Kawai M; Ohzato H; Ukei T
    Transplant Proc; 1990 Feb; 22(1):66-71. PubMed ID: 1689904
    [No Abstract]   [Full Text] [Related]  

  • 10. Side effects of FK 506 in cynomolgus monkeys: a histopathologic study.
    Tiebosch A; Ericzon BG; Wijnen R; Arends JW; Groth CG; Kootstra G
    Transplant Proc; 1990 Aug; 22(4):1652. PubMed ID: 1697115
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of FK 506 on the thymus: implications of drug-induced injury to thymic epithelial cells.
    Thomson AW; Pugh-Humphreys RG; Woo J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):947-8. PubMed ID: 1703361
    [No Abstract]   [Full Text] [Related]  

  • 12. FK 506--an investigational immunosuppressant.
    Med Lett Drugs Ther; 1991 Oct; 33(854):94. PubMed ID: 1716722
    [No Abstract]   [Full Text] [Related]  

  • 13. Infections in adult liver transplant patients under FK 506 immunosuppression.
    Alessiani M; Kusne S; Martin M; Jain A; Abu-Elmagd K; Moser J; Todo S; Fung J; Starzl T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1501-3. PubMed ID: 1703345
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicologic evaluation of FK 506.
    Ohara K; Billington R; James RW; Dean GA; Nishiyama M; Noguchi H
    Transplant Proc; 1990 Feb; 22(1):83-6. PubMed ID: 1689910
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
    Fung JJ; Todo S; Tzakis A; Demetris A; Jain A; Abu-Elmaged K; Alessiani M; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):14-21. PubMed ID: 1703682
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of hepatic ischemia-reperfusion injury on tacrolimus acute renal toxicity in pigs.
    Espí A; Regueira FM; Toledo G; Díez-Caballero A; Baixaulí J; Hernández JL; Rotellar F; Pardo E; Cienfuegos JA
    Transplant Proc; 2002 Dec; 34(8):3053-6. PubMed ID: 12493373
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation.
    Kang Y; Mazer MA; DeWolf AM; Fung JJ; Gasior T; Venkataramanan R; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):21-2. PubMed ID: 1689889
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 19. FK 506: an immunosuppressant for the 1990s?
    Macleod AM; Thomson AW
    Lancet; 1991 Jan; 337(8732):25-7. PubMed ID: 1702172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic and nephrotoxicity of immunomodulator compounds.
    Hammond TG; Kind CN
    Toxicol Lett; 1995 Dec; 82-83():99-105. PubMed ID: 8597171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.